# OnCo record in-vivo-car-t (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/in-vivo-car-t/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "in-vivo-car-t" ;
  schema:name "In vivo CAR-T"@en ;
  schema:description "Instead of engineering T cells in a factory, an injection reprograms them inside the patient's body."@en ;
  schema:url <https://onco.cc/technologies/in-vivo-car-t/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://doi.org/10.15252/emmm.201809158> ;
  onco:status "phase-1" ;
  onco:tag "frontier" ;
  onco:sections <https://onco.cc/fronts/cell-therapy/> ;
  onco:technologies <https://onco.cc/technologies/car-t/> ;
  onco:companies <https://onco.cc/companies/abbvie/>, <https://onco.cc/companies/adicet-bio/>, <https://onco.cc/companies/capstan-therapeutics/>, <https://onco.cc/companies/kelonia-therapeutics/>, <https://onco.cc/companies/kernal-biologics/>, <https://onco.cc/companies/strand-therapeutics/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-pfeiffer-embo-mol-med/> .